tirzepatide gip glp 1 Tirzepatide: A Novel, Once-weekly Dual and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes Tirzepatide | GLP-1R and GIPR

Low FODMAP The low FODMAP meal plan eliminates high fermentable food sources

The Metabolic Connection At Kings Community Development Global Initiative, we recognize the growing burden of hypertension as not just a cardiovascular challenge but a metabolic risk factor, a key player in the cardiovascular kidney metabolic (CKM) syndrome now emphasized in the 2025 AHA/ACC Blood Pressure Guideline

Clinical trials have shown the impressive weight loss potential of Semaglutide

Subjects included healthy volunteers and subjects with renal or hepatic impairment, a small number of whom also had T2D

Unlike statins, these medications do not have known myotoxic effects on muscle cells